How e-cigarette exposure during pregnancy affects blood clotting
The Impact of In Utero E-Cigarette Exposure on Platelet Function and Thrombogenesis
This study is looking at how being around e-cigarettes during pregnancy might affect the development of blood platelets in babies and their risk of blood clotting problems later on, so it’s especially for expectant moms who use e-cigarettes or are around them.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10640062 on NIH RePORTER |
What this research studies
This research investigates the effects of e-cigarette exposure during pregnancy on the development of blood platelets and the risk of blood clotting disorders in offspring. It aims to understand the biological mechanisms and health implications of in utero exposure to e-cigarettes, particularly focusing on how it may contribute to thrombotic diseases. The study employs a novel whole-body exposure model to assess the impact of e-cigarettes on platelet function and related health outcomes. By examining these factors, the research seeks to clarify the potential risks associated with e-cigarette use among pregnant women.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant women who use e-cigarettes or have been exposed to e-cigarettes during pregnancy.
Not a fit: Patients who do not use e-cigarettes or are not pregnant may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide critical insights into the health risks of e-cigarette use during pregnancy, potentially leading to better health guidelines and interventions for expectant mothers.
How similar studies have performed: While traditional smoking's impact on thrombotic diseases is well-documented, the specific effects of e-cigarettes are less understood, making this research a novel exploration in this area.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Alshbool, Fatima Z. — Texas A&m University Health Science Ctr
- Study coordinator: Alshbool, Fatima Z.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.